Consolidated Statements of Changes In Equity (Deficit) - USD ($) $ in Thousands |
Share capital and premium |
Treasury shares |
Share options |
Reserve for transactions with noncontrolling interests |
Reserve for share-based payment transactions |
Reserve for remeasurement of defined benefit plan |
Foreign currency translation adjustments |
Accumulated deficit |
Total |
Non- controlling interests |
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2021 | $ 70,762 | $ (1,230) | $ 1,102 | $ 9,574 | $ (608) | $ 2,634 | $ (17,447) | $ 64,787 | $ 991 | $ 65,778 | |
| Total net loss | (81,595) | (81,595) | 1,595 | (80,000) | |||||||
| Other comprehensive loss | (154) | (5,346) | (5,500) | (94) | (5,594) | ||||||
| Total comprehensive income (loss) | (154) | (5,346) | (81,595) | (87,095) | 1,501 | (85,594) | |||||
| Warrants exercise | 451 | (81) | 370 | 370 | |||||||
| Options exercise | 2,553 | (1,837) | 716 | 716 | |||||||
| Extension of options to equity holders of the Company (Note 18f) | (5,102) | 5,102 | |||||||||
| Dividend distribution to non-controlling interests | (95) | (95) | |||||||||
| Issuance of shares and options, net of issuance expenses (Note 20) | 12,956 | 4,087 | 76 | 17,119 | 17,119 | ||||||
| Cost of share-based payment | 10,516 | 10,516 | 10,516 | ||||||||
| Balance at Dec. 31, 2022 | 81,620 | (1,230) | 10,291 | 76 | 18,172 | (762) | (2,712) | (99,042) | 6,413 | 2,397 | 8,810 |
| Total net loss | (87,446) | (87,446) | 810 | (86,636) | |||||||
| Other comprehensive loss | 92 | (878) | (786) | (62) | (848) | ||||||
| Total comprehensive income (loss) | 92 | (878) | (87,446) | (88,232) | 748 | (87,484) | |||||
| Warrants exercise | 286 | (52) | 234 | 234 | |||||||
| Options exercise | 2,893 | (1,122) | 1,771 | 1,771 | |||||||
| Issuance of shares to Equity line of Credit (“ELOC’) | 1,570 | 1,570 | 1,570 | ||||||||
| Conversion of convertible loans | 6,143 | 6,143 | 6,143 | ||||||||
| Issuance of shares and warrants related to the PIPE, net of issuance expenses | 3,557 | 3,557 | 3,557 | ||||||||
| Issuance of shares and warrants | 110 | 679 | (76) | 712 | 712 | ||||||
| Issuance of shares related to RNER merger transaction (Note 5) | 7,208 | 7,208 | 7,208 | ||||||||
| Dividend distribution to non-controlling interests | (369) | (369) | |||||||||
| Cost of share-based payment | 7,115 | 7,115 | 7,115 | ||||||||
| Balance at Dec. 31, 2023 | 103,386 | (1,230) | 10,918 | 24,165 | (670) | (3,590) | (186,488) | (53,509) | 2,776 | (50,733) | |
| Total net loss | (39,757) | (39,757) | 726 | (39,031) | |||||||
| Other comprehensive loss | 168 | (192) | (24) | (50) | (74) | ||||||
| Total comprehensive income (loss) | 168 | (192) | (39,757) | (39,781) | 676 | (39,105) | |||||
| Warrants exercise | 3,422 | 3,422 | 3,422 | ||||||||
| Options exercise | 143 | (142) | 1 | 1 | |||||||
| Conversion of convertible loans | 7,876 | 7,876 | 7,876 | ||||||||
| Issuance of shares and warrants | 2,420 | 2,420 | 2,420 | ||||||||
| Transactions with Non controlling interest | (3,286) | (3,286) | (3,482) | (6,768) | |||||||
| Cost of share-based payment | 2,070 | 2,070 | 2,070 | ||||||||
| Balance at Dec. 31, 2024 | $ 117,247 | $ (1,230) | $ 10,918 | $ (3,286) | $ 26,093 | $ (502) | $ (3,782) | $ (226,245) | $ (80,787) | $ (30) | $ (80,817) |